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Background: Radiation therapy (RT) is considered a risk factor for the development of sarcoma in patients with
breast cancer. However, there are few reports regarding post-irradiation sarcoma (PIS).
Case presentation: The patient was a 59-year-old woman who presented with a chief complaint of induration in
the lower outer quadrant of the left breast. She underwent breast-conserving surgery (BCS) for breast cancer
located in the left upper inner region and received endocrine therapy following RT (50 Gy/25 fractions/5 weeks)
for breast conservation 6 years previously. Core needle biopsy revealed leiomyosarcoma. There was no distant
metastasis. Repeat BCS including part of the pectoralis major muscle was performed. Chest wall resection was not
performed because of the lack of invasion. Based on the morphological and immunohistochemical features, a
diagnosis of leiomyosarcoma was made. All of the resection margins in the specimen were tumor-free. She has
been disease-free for over 20 months.
Conclusions: Post-irradiation leiomyosarcoma is an extremely rare tumor with high malignant potential, and thus,
multidisciplinary therapy and close follow-up are advised.
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The combination of breast-conserving surgery (BCS) and
radiation therapy (RT) has become a standard treatment
for breast cancer. Adverse events are occasionally ob-
served following RT, and post-irradiation sarcoma (PIS) is
one of the serious events. Some reports have documented
the occurrence of post-irradiation angiosarcoma. However,
few reports have described post-irradiation leiomyosar-
coma of the breast. We report a case of a post-irradiation
leiomyosarcoma that developed following BCS with RT.Case presentation
A 59-year-old woman was referred to our hospital with
a lump located in the lower outer quadrant of the left
breast. She underwent BCS as well as endocrine therapy
and RT (50 Gy/25 fractions/5 weeks) delivered to the re-
sidual breast for breast cancer of the left breast upper* Correspondence: shayashi@asahikawa-med.ac.jp
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vealed a 20-mm firm lump fixed to the underlying pec-
toralis major muscle. The overlying skin was free of
tumor. There was no palpable axillary lymph node.
Mammography revealed a focal asymmetrical density in
the retromammary space. Ultrasonography revealed a
lobulated and well-defined mass (17.5 × 16.4 × 10.6 mm
in size) with relatively hypoechoic, heterogeneous in-
ternal echoes. Core needle biopsy (CNB) of the lump
suggested atrophic mammary glands. The tumor had in-
creased in size after 3 months of follow-up. Re-CNB was
performed, and pathological diagnosis was leiomyosar-
coma. On positron emission tomography with 18F-fluor-
odeoxyglucose, the maximum standardized uptake value
was 12.7, which corresponded to the tumor finding on
computed tomography (Fig. 1a, b). The tumor was lim-
ited to the breast and pectoralis major muscle, and there
was no distant metastasis. Biochemical blood examina-
tions did not reveal abnormalities. She underwent local
excision of the mass with a 2-cm margin including the
skin and pectoralis major muscle under generalis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Fig. 1 Imaging findings. On positron emission tomography (PET), the
maximum standardized uptake value was 12.7, which corresponded to
the tumor finding on computed tomography (CT). a CT. b PET
Fig. 3 Pathological findings (magnification ×200). The tumor was a
30 × 23 mm tumor with atypical spindle cells arranged in a fascicular
histoid pattern. Immunohistochemistry demonstrated that the tumor
cells were positive for α-smooth muscle actin (α-SMA), desmin, and
vimentin. a Hematoxylin-eosin staining. b α-SMA. c Desmin. d Vimentin
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grayish with smooth margins (Fig. 2). Postoperative
histopathology revealed a 30 × 23 mm tumor with atyp-
ical spindle cells arranged in a fascicular histoid pattern
(Fig. 3a). Immunohistochemistry demonstrated that the
tumor cells were positive for α-smooth muscle actin
(α-SMA), desmin, and vimentin (Fig. 3b–d). Based on
the morphological and immunohistochemical features,
the tumor was diagnosed as leiomyosarcoma. Our
findings for this case corresponded with the criteria for
PIS [1]. All of the resection margins were free of tumor.
She has been alive for 20 months without recurrence.
Conclusions
We reported a case of post-irradiation leiomyosarcoma
that developed following BCS. The incidence of PIS may
continue to increase because of the combined use of
BCS and RT as a standard therapy for breast cancer.
There are some prior reports regarding PIS. However,
most of these reports described post-irradiation angio-
sarcoma instead of leiomyosarcoma. Yap et al. [2] re-
ported that among sarcomas occurring within the RT
field, angiosarcoma accounted for 56.8 % of the lesions,
with malignant fibrous histiocytoma (MFH) accounting
for 15.9 %, fibrosarcoma and chondrosarcoma accountingFig. 2 Macroscopic appearance of the resected tumor. The tumor
was solid and grayish with smooth marginsfor 6.8 %, and leiomyosarcoma accounting for 4.5 % of the
lesions.
The latency period between RT and the appearance of
PIS ranges from 4 to 36 years with a mean of 12 years,
and the average radiation dose was 53 Gy [3]. There was
no difference between patients treated with megavoltage
radiation and those treated with orthovoltage radiation
concerning the type of sarcoma, its location, or survival
rates [4]. This means that the occurrence of PIS is a sto-
chastic effect instead of a deterministic effect.
PIS is often difficult to diagnose in patients with fibro-
sis legions after RT, and thus, the diagnosis may occur
late [3]. In our case, we could diagnose post-irradiation
leiomyoma after re-biopsy. Therefore, it may be neces-
sary to perform excisional biopsy to exclude the possibil-
ity of PIS.
Appropriate morphological features should distinguish
leiomyosarcoma of the breast. In addition, immunohisto-
chemical analysis is a useful diagnostic tool. The differ-
ential diagnosis of leiomyosarcoma includes various
types of sarcoma, such as fibrosarcoma, MFH, and phyl-
lodes tumor. In leiomyosarcoma, tumor cells are positive
for α-SMA, desmin, and vimentin and negative for cyto-
keratin, epithelial membrane antigen, and S-100 [5]. In
our case, immunohistochemistry revealed that the tumor
cells were positive for α-SMA, desmin, and vimentin.
Among the treatment options for primary leiomyosar-
coma, surgery is generally considered the primary treat-
ment [6]. In contrast, des Guetz et al. reported that in a
neoadjuvant therapy group of 19 patients who received
chemotherapy, nine patients achieved a clinical partial
response [3]. In addition, two post-irradiated histologic
subtypes, leiomyosarcoma and undifferentiated sarcoma,
were associated with greater clinical responses than the
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therapy should be considered in the treatment of PIS, in
contrast to primary sarcomas. We have to include both
repeat surgery and chemotherapy in the treatment plan
in cases of recurrence of distant metastasis.
The prognosis for patients with PIS is reported to be
dismal, with a median survival time ranging from 2.3 [2]
to 2.6 years [3], and the 2-year survival rate has been re-
ported as 32 % [4]. However, survival was much better
in patients who responded to neoadjuvant chemotherapy
and those who underwent surgery.
We reported the first case of post-irradiation leiomyo-
sarcoma of the breast in Japan. In addition, this malig-
nancy is rare globally. However, the lesion in our patient
may have been primary leiomyosarcoma, and leiomyo-
sarcoma of the breast is extremely rare. Further research
is required. Both surgery and chemotherapy are import-
ant treatment options for post-irradiation leiomyosar-
coma, and close follow-up are advised.
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